학술논문
Supplement to: JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.
Document Type
Academic Journal
Author
Source
The New England Journal of Medicine. Mar 01, 2012 366(9)
Subject
Language
English
ISSN
0028-4793